LLY has been in the news 309% more than usual
Feb 23, 2026, 5:32 PM
-14.92%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Data from REDEFINE 4 showed Novo Nordisk’s CagriSema produced 20.2% weight loss versus 23.6% for Eli Lilly’s tirzepatide, prompting a sharp drop in Novo Nordisk shares. Large investors remain bullish on Eli Lilly (NYSE: LLY), signaling strong confidence in the company’s stock.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.